Andrew Gausepohl, BSc, MSc
Biomedical Sciences PhD Student at the Albert Einstein College of Medicine
Education:
- Bachelor of Science in Molecular and Cellular Biology, Johns Hopkins University
While in the Williams' lab, I studied the impacts of SIV-infection on brain lipid metabolism by MALDI-MS as well as the impact of Dolutegravir on monocyte metabolism. I am currently characterizing how buprenorphine, a drug used in the treatment of opioid use disorder, may limit mature monocyte transmigration across the blood brain barrier and potentially be used to treat HIV associated neurocognitive impairment
Honors and Awards:
- Training in HIV/AIDS Pathogenesis; Basic and Translational Research T32 recipient (T32 AI007501), 2023-24
- Johns Hopkins Margolies Research Award (for outstanding undergraduate research), 2022
- General and Departmental Honors from Johns Hopkins University, 2022
- Johns Hopkins Life Design Lab’s SOAR Summer Plunge Grant, 2021
- White CJ*, Gausepohl AM*, Wilkins HN, Eberhard CD, Orsburn BC, Williams DW. Spatial Heterogeneity of Brain Lipids in SIV-Infected Macaques Treated with Antiretroviral Therapy. J Am Soc Mass Spectrom. 2024 Feb 7;35(2):185-196. doi: 10.1021/jasms.3c00276. Epub 2024 Jan 30. PMID: 38288997
- I am completing my Ph.D. in the same lab that Dionna got her Ph.D. in!